Watch Ticker

Medicinova, Inc.

Go to Medicinova, Inc. Website

$1.48

(%)
Live
Previous Close

$1.48

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$72.6 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

LA JOLLA, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-166 (ibudilast) for the treatment of chlorine-induced acute respiratory distress syndrome (ARDS).

Related tickers: MNOV.

Read Full Article

LA JOLLA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received an issue notification from the U.S. Patent and Trademark Office for a new patent which covers extended-release oral formulations of MN-166 (ibudilast). This new patent is expected to expire no earlier than September 2040. The allowed claims cover a formulation in the form of a tablet or capsule and cover a range of doses of MN-166 (ibudilast).

Related tickers: MNOV.

Read Full Article
Trending Tickers
BTTX

XNAS

$0.00
(%)
OPRT

XNAS

$0.00
(%)
PALI

XNAS

$6.24
(%)
PRSO

XNAS

$1.42
(%)
ACRV

XNAS

$8.36
(%)